Skip to content
ppharmaranks
Menu

ABIRATERONE ACETATE vs KISQALI FEMARA CO-PACK (COPACKAGED)

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. ABIRATERONE ACETATE and KISQALI FEMARA CO-PACK (COPACKAGED) are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
70/100

Pharmacy pays

~$25.50 /30
~$4.37 /30

Type

RX
RX

Active ingredient

ABIRATERONE ACETATE
LETROZOLE AND RIBOCICLIB SUCCINATE

Manufacturer

Dosage forms

Tablet
Kit

Drug class

Cytochrome P450 17a1 Inhibitor

Boxed warning

None
None

Half-life

about 2 days (terminal elimination half-life)

Treats

Castration-Resistant Prostatic Neoplasms

Frequently asked questions

Which is better-rated, Abiraterone Acetate or Kisqali Femara Co-Pack (Copackaged)?

By our independent rating, Abiraterone Acetate scores higher — 3.6 vs 3.5 out of 5 for Kisqali Femara Co-Pack (Copackaged). Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Abiraterone Acetate or Kisqali Femara Co-Pack (Copackaged)?

Kisqali Femara Co-Pack (Copackaged) costs pharmacies less to acquire — about $4.37 vs $25.50 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Abiraterone Acetate and Kisqali Femara Co-Pack (Copackaged)?

Abiraterone Acetate contains Abiraterone Acetate, while Kisqali Femara Co-Pack (Copackaged) contains Letrozole and Ribociclib Succinate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.